Hepatology
News
CDC: Screen nearly all adults, including pregnant women, for HCV
News
Noninvasive fibrosis scores not sensitive in people with fatty liver disease and T2D
Alternatives to liver biopsy are less than ideal for detecting advanced fibrosis in patients with underlying diabetes.
News
HCV screening risk factors in pregnant women need updating
Large study of pregnant women highlights the potential value of universal screening for hepatitis C virus.
News
Screen all adults for hepatitis C, says USPSTF
The U.S. Preventive Services Task Force now recommends that asymptomatic adults ages 18-79 be screened for hepatitis C virus infection.
Conference Coverage
HBV: Rethink the free pass for immune tolerant patients
MAUI, HAWAII – Not treating means more liver cancer.
Conference Coverage
NASH ‘an epidemic of the 21st century’
LOS ANGELES – Recent guidelines recognize the association between diabetes, NAFLD, and NASH, and call for more vigilance and screening tests.
Conference Coverage
Novel approaches to treating NASH in diabetes
BARCELONA –
Conference Coverage
What’s new in hepatitis C: Four themes that dominated at the Liver Meeting
BOSTON – AASLD highlights included treatment of persons who inject drugs, new directions in pangenotypic therapy,...
News
AASLD debrief: Five drugs show promise in NAFLD (and two do not)
BOSTON – Promising new data for cotadutide, licogliflozin, tropifexor, saroglitazar, and PF-05221304 highlighted in...
Conference Coverage
TARGET-NASH: One-third of NAFLD, NASH patients lost weight, but not all kept it off
BOSTON – With no approved pharmacologic treatments for NAFLD and NASH, weight reduction remains one of the mainstays of treatment.